home.social

#covalentinhibitors — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #covalentinhibitors, aggregated by home.social.

fetched live
  1. GTPases have long been considered key examples of undruggable proteins. While this has been overcome for K-Ras using #CovalentInhibitors, for many other family member #DrugDevelopment has not been shown.

    Congratulations to Johannes Morstein on winning one of the @GDCh_BioChem Young Scientist Awards for his work addressing this challenge by identifying druggable, allosteric pockets in several GTPases.

    cell.com/cell/fulltext/S0092-8
    #Biochemistry #ChemBio #GTP #GTPases #Chemistry
    CC: @gdch

  2. GTPases have long been considered key examples of undruggable proteins. While this has been overcome for K-Ras using #CovalentInhibitors, for many other family member #DrugDevelopment has not been shown.

    Congratulations to Johannes Morstein on winning one of the @GDCh_BioChem Young Scientist Awards for his work addressing this challenge by identifying druggable, allosteric pockets in several GTPases.

    cell.com/cell/fulltext/S0092-8
    #Biochemistry #ChemBio #GTP #GTPases #Chemistry
    CC: @gdch

  3. GTPases have long been considered key examples of undruggable proteins. While this has been overcome for K-Ras using #CovalentInhibitors, for many other family member #DrugDevelopment has not been shown.

    Congratulations to Johannes Morstein on winning one of the @GDCh_BioChem Young Scientist Awards for his work addressing this challenge by identifying druggable, allosteric pockets in several GTPases.

    cell.com/cell/fulltext/S0092-8
    #Biochemistry #ChemBio #GTP #GTPases #Chemistry
    CC: @gdch

  4. GTPases have long been considered key examples of undruggable proteins. While this has been overcome for K-Ras using #CovalentInhibitors, for many other family member #DrugDevelopment has not been shown.

    Congratulations to Johannes Morstein on winning one of the @GDCh_BioChem Young Scientist Awards for his work addressing this challenge by identifying druggable, allosteric pockets in several GTPases.

    cell.com/cell/fulltext/S0092-8
    #Biochemistry #ChemBio #GTP #GTPases #Chemistry
    CC: @gdch

  5. Great talk by Akane Kawamura at #Biochemistry2026. She talked about her group's exciting work on the #Biochemistry of JmjC demethylases with important implications for #epigenetics. Exciting insights into arginine demethylation.

    febs.onlinelibrary.wiley.com/d

    She also talked about the potential of these enzymes in #DrugDiscovery including the discovery of #CovalentInhibitors for KDM5.

    onlinelibrary.wiley.com/doi/fu
    #Chemistry #ChemBio #Biochemistry
    CC: @gdch, @GDCh_BioChem

  6. Great talk by Akane Kawamura at #Biochemistry2026. She talked about her group's exciting work on the #Biochemistry of JmjC demethylases with important implications for #epigenetics. Exciting insights into arginine demethylation.

    febs.onlinelibrary.wiley.com/d

    She also talked about the potential of these enzymes in #DrugDiscovery including the discovery of #CovalentInhibitors for KDM5.

    onlinelibrary.wiley.com/doi/fu
    #Chemistry #ChemBio #Biochemistry
    CC: @gdch, @GDCh_BioChem

  7. Great talk by Akane Kawamura at #Biochemistry2026. She talked about her group's exciting work on the #Biochemistry of JmjC demethylases with important implications for #epigenetics. Exciting insights into arginine demethylation.

    febs.onlinelibrary.wiley.com/d

    She also talked about the potential of these enzymes in #DrugDiscovery including the discovery of #CovalentInhibitors for KDM5.

    onlinelibrary.wiley.com/doi/fu
    #Chemistry #ChemBio #Biochemistry
    CC: @gdch, @GDCh_BioChem

  8. Great talk by Akane Kawamura at #Biochemistry2026. She talked about her group's exciting work on the #Biochemistry of JmjC demethylases with important implications for #epigenetics. Exciting insights into arginine demethylation.

    febs.onlinelibrary.wiley.com/d

    She also talked about the potential of these enzymes in #DrugDiscovery including the discovery of #CovalentInhibitors for KDM5.

    onlinelibrary.wiley.com/doi/fu
    #Chemistry #ChemBio #Biochemistry
    CC: @gdch, @GDCh_BioChem

  9. I was very happy to be able to talk about some of our work at #Biochemistry2026. I presented results of Patrick Zanon, Marnix Roseboom, Julia Pols and Storm van der Voort on new covalently reactive groups, chemical proteomics methods and screening technologies.

    nature.com/articles/s41557-025
    #Chemistry #ChemBio #Biochemistry #Chemoproteomics #CovalentInhibitors

  10. I was very happy to be able to talk about some of our work at #Biochemistry2026. I presented results of Patrick Zanon, Marnix Roseboom, Julia Pols and Storm van der Voort on new covalently reactive groups, chemical proteomics methods and screening technologies.

    nature.com/articles/s41557-025
    #Chemistry #ChemBio #Biochemistry #Chemoproteomics #CovalentInhibitors

  11. I was very happy to be able to talk about some of our work at #Biochemistry2026. I presented results of Patrick Zanon, Marnix Roseboom, Julia Pols and Storm van der Voort on new covalently reactive groups, chemical proteomics methods and screening technologies.

    nature.com/articles/s41557-025
    #Chemistry #ChemBio #Biochemistry #Chemoproteomics #CovalentInhibitors

  12. I was very happy to be able to talk about some of our work at #Biochemistry2026. I presented results of Patrick Zanon, Marnix Roseboom, Julia Pols and Storm van der Voort on new covalently reactive groups, chemical proteomics methods and screening technologies.

    nature.com/articles/s41557-025
    #Chemistry #ChemBio #Biochemistry #Chemoproteomics #CovalentInhibitors

  13. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  14. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  15. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  16. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  17. Let's start the year off right with an exciting paper post!

    In this Chemical Communications paper, the groups of Megan Wright and Stuart Warriner investigate the metal-independent labeling of proteins using isocyanides.

    pubs.rsc.org/en/content/articl
    #ChemBio #Chemistry #CovalentInhibitors

  18. Let's start the year off right with an exciting paper post!

    In this Chemical Communications paper, the groups of Megan Wright and Stuart Warriner investigate the metal-independent labeling of proteins using isocyanides.

    pubs.rsc.org/en/content/articl
    #ChemBio #Chemistry #CovalentInhibitors

  19. Let's start the year off right with an exciting paper post!

    In this Chemical Communications paper, the groups of Megan Wright and Stuart Warriner investigate the metal-independent labeling of proteins using isocyanides.

    pubs.rsc.org/en/content/articl
    #ChemBio #Chemistry #CovalentInhibitors

  20. Let's start the year off right with an exciting paper post!

    In this Chemical Communications paper, the groups of Megan Wright and Stuart Warriner investigate the metal-independent labeling of proteins using isocyanides.

    pubs.rsc.org/en/content/articl
    #ChemBio #Chemistry #CovalentInhibitors

  21. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  22. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  23. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  24. Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
    pubs.acs.org/doi/10.1021/acs.j
    #Chemistry #ChemBio #DrugDiscovery #Kinases

  25. Amazing paper by the groups of Li Ye and Ben Cravatt of @scripps.edu in @cp-cell.bsky.social. They developed the vCATCH method to map in vivo, to which tissues and cell types #CovalentInhibitors bind with spatial resolution in whole intact mouse bodies. cell.com/cell/fulltext/S0092-8
    #Chemistry #ChemBio

  26. Amazing paper by the groups of Li Ye and Ben Cravatt of @scripps.edu in @cp-cell.bsky.social. They developed the vCATCH method to map in vivo, to which tissues and cell types #CovalentInhibitors bind with spatial resolution in whole intact mouse bodies. cell.com/cell/fulltext/S0092-8
    #Chemistry #ChemBio

  27. Amazing paper by the groups of Li Ye and Ben Cravatt of @scripps.edu in @cp-cell.bsky.social. They developed the vCATCH method to map in vivo, to which tissues and cell types #CovalentInhibitors bind with spatial resolution in whole intact mouse bodies. cell.com/cell/fulltext/S0092-8
    #Chemistry #ChemBio

  28. Amazing paper by the groups of Li Ye and Ben Cravatt of @scripps.edu in @cp-cell.bsky.social. They developed the vCATCH method to map in vivo, to which tissues and cell types #CovalentInhibitors bind with spatial resolution in whole intact mouse bodies. cell.com/cell/fulltext/S0092-8
    #Chemistry #ChemBio

  29. Very excited to see this study by the group of David Konrad out in JACS Au.

    Ortho-dichloroacrylophenone is a highly reactive, cysteine-directed electrophile for peptide and protein labeling as well as chemoproteomic profiling. Glad that our group could make a small contribution.

    pubs.acs.org/doi/10.1021/jacsa
    #ChemBio #Chemistry #ChemPro #ProteoProbes #CovalentInhibitors

  30. Very excited to see this study by the group of David Konrad out in JACS Au.

    Ortho-dichloroacrylophenone is a highly reactive, cysteine-directed electrophile for peptide and protein labeling as well as chemoproteomic profiling. Glad that our group could make a small contribution.

    pubs.acs.org/doi/10.1021/jacsa
    #ChemBio #Chemistry #ChemPro #ProteoProbes #CovalentInhibitors

  31. Very excited to see this study by the group of David Konrad out in JACS Au.

    Ortho-dichloroacrylophenone is a highly reactive, cysteine-directed electrophile for peptide and protein labeling as well as chemoproteomic profiling. Glad that our group could make a small contribution.

    pubs.acs.org/doi/10.1021/jacsa
    #ChemBio #Chemistry #ChemPro #ProteoProbes #CovalentInhibitors

  32. Interesting paper by the group of Alexander Dömling in Green Chemistry. They used an Ugi four-component reaction followed by product precipitation for the efficient synthesis and purification of a >1200-member acrylamide library.

    pubs.rsc.org/en/content/articl
    #CovalentInhibitors #Chemistry #ChemBio

  33. Interesting paper by the group of Alexander Dömling in Green Chemistry. They used an Ugi four-component reaction followed by product precipitation for the efficient synthesis and purification of a >1200-member acrylamide library.

    pubs.rsc.org/en/content/articl
    #CovalentInhibitors #Chemistry #ChemBio

  34. Interesting paper by the group of Alexander Dömling in Green Chemistry. They used an Ugi four-component reaction followed by product precipitation for the efficient synthesis and purification of a >1200-member acrylamide library.

    pubs.rsc.org/en/content/articl
    #CovalentInhibitors #Chemistry #ChemBio

  35. "Rapid Antibiotic Discovery using a Direct-to-Biology Approach"

    Storm van der Voort from the group of Hermen Overkleeft and our group at the @LED3hub presented his exciting research into efficiently finding new antibacterially active #CovalentInhibitors using a direct-to-biology approach and into finding their targets using residue-specific chemoproteomics with the isoDTB-ABPP technology at #NWOCHAINS.

    #Bacteria #Antibiotics #Chemistry #ChemBio #ChemicalProteomics #D2B

  36. "Rapid Antibiotic Discovery using a Direct-to-Biology Approach"

    Storm van der Voort from the group of Hermen Overkleeft and our group at the @LED3hub presented his exciting research into efficiently finding new antibacterially active #CovalentInhibitors using a direct-to-biology approach and into finding their targets using residue-specific chemoproteomics with the isoDTB-ABPP technology at #NWOCHAINS.

    #Bacteria #Antibiotics #Chemistry #ChemBio #ChemicalProteomics #D2B

  37. "Rapid Antibiotic Discovery using a Direct-to-Biology Approach"

    Storm van der Voort from the group of Hermen Overkleeft and our group at the @LED3hub presented his exciting research into efficiently finding new antibacterially active #CovalentInhibitors using a direct-to-biology approach and into finding their targets using residue-specific chemoproteomics with the isoDTB-ABPP technology at #NWOCHAINS.

    #Bacteria #Antibiotics #Chemistry #ChemBio #ChemicalProteomics #D2B

  38. Insightful talk by Dieuwertje Streefkerk at #NWOCHAINS. She talked about their synthetic work on stereochemically defined sulfur(VI) electrophiles and their use as #CovalentInhibitors on the example of chymotrypsin inhibition.

    onlinelibrary.wiley.com/doi/ab
    onlinelibrary.wiley.com/doi/fu
    #Chemistry #ChemBio #Electrophiles

  39. Insightful talk by Dieuwertje Streefkerk at #NWOCHAINS. She talked about their synthetic work on stereochemically defined sulfur(VI) electrophiles and their use as #CovalentInhibitors on the example of chymotrypsin inhibition.

    onlinelibrary.wiley.com/doi/ab
    onlinelibrary.wiley.com/doi/fu
    #Chemistry #ChemBio #Electrophiles

  40. Insightful talk by Dieuwertje Streefkerk at #NWOCHAINS. She talked about their synthetic work on stereochemically defined sulfur(VI) electrophiles and their use as #CovalentInhibitors on the example of chymotrypsin inhibition.

    onlinelibrary.wiley.com/doi/ab
    onlinelibrary.wiley.com/doi/fu
    #Chemistry #ChemBio #Electrophiles

  41. Great talk by Marta Artola at #NWOCHAINS. She talked about the use of modified sugars as inhibitors and molecular #chaperones in #DrugDiscovery. Exciting insights into the use of cyclic sulfamates and sulfamidates as reactive groups for #CovalentInhibitors.
    pubs.acs.org/doi/10.1021/acsce
    #Chemistry #ChemBio

  42. Great talk by Marta Artola at #NWOCHAINS. She talked about the use of modified sugars as inhibitors and molecular #chaperones in #DrugDiscovery. Exciting insights into the use of cyclic sulfamates and sulfamidates as reactive groups for #CovalentInhibitors.
    pubs.acs.org/doi/10.1021/acsce
    #Chemistry #ChemBio

  43. Great talk by Marta Artola at #NWOCHAINS. She talked about the use of modified sugars as inhibitors and molecular #chaperones in #DrugDiscovery. Exciting insights into the use of cyclic sulfamates and sulfamidates as reactive groups for #CovalentInhibitors.
    pubs.acs.org/doi/10.1021/acsce
    #Chemistry #ChemBio

  44. We explored the question, from which different areas of chemistry, including glycochemistry, peptide chemistry, materials chemistry and synthetic method development new electrophiles for covalent inhibitors can originate in order to keep expanding the druggable space. (2/2)

    #Chemistry #ChemBio #ChemicalProteomics #ChemPro #ProteoProbes #DrugDiscovery #Glycotime #Peptides #Materials #Synthesis #Undruggable #CovalentInhibitors

  45. We explored the question, from which different areas of chemistry, including glycochemistry, peptide chemistry, materials chemistry and synthetic method development new electrophiles for covalent inhibitors can originate in order to keep expanding the druggable space. (2/2)

    #Chemistry #ChemBio #ChemicalProteomics #ChemPro #ProteoProbes #DrugDiscovery #Glycotime #Peptides #Materials #Synthesis #Undruggable #CovalentInhibitors

  46. We explored the question, from which different areas of chemistry, including glycochemistry, peptide chemistry, materials chemistry and synthetic method development new electrophiles for covalent inhibitors can originate in order to keep expanding the druggable space. (2/2)

    #Chemistry #ChemBio #ChemicalProteomics #ChemPro #ProteoProbes #DrugDiscovery #Glycotime #Peptides #Materials #Synthesis #Undruggable #CovalentInhibitors

  47. Now I am looking forward to two days of exciting science, including our focus session on #CovalentInhibitors as well as many exciting presentations by #PhD and #postdoc researchers. (8/8)

  48. Now I am looking forward to two days of exciting science, including our focus session on #CovalentInhibitors as well as many exciting presentations by #PhD and #postdoc researchers. (8/8)

  49. Now I am looking forward to two days of exciting science, including our focus session on #CovalentInhibitors as well as many exciting presentations by #PhD and #postdoc researchers. (8/8)

  50. Are you interested in novel covalent inhibitors and diverse strategies, through which you can find new chemistries for them? Then check out our Focus Session on "Covalent Inhibitors and where to find them" at the CHAINS conference by NWO. (1/4) #Chemistry #CovalentInhibitors #ChemBio #DrugDiscovery

  51. Are you interested in novel covalent inhibitors and diverse strategies, through which you can find new chemistries for them? Then check out our Focus Session on "Covalent Inhibitors and where to find them" at the CHAINS conference by NWO. (1/4) #Chemistry #CovalentInhibitors #ChemBio #DrugDiscovery

  52. Are you interested in novel covalent inhibitors and diverse strategies, through which you can find new chemistries for them? Then check out our Focus Session on "Covalent Inhibitors and where to find them" at the CHAINS conference by NWO. (1/4) #Chemistry #CovalentInhibitors #ChemBio #DrugDiscovery

  53. Are you interested in novel covalent inhibitors and diverse strategies, through which you can find new chemistries for them?

    I am very excited that Madeline Kavanagh, Marc Baggelaar, Rita Petracca and I were awarded a Focus Session on "Covalent Inhibitors and where to find them" at the CHAINS conference by NWO to discuss exactly these topics. (1/3)

    nwochains.nl/programme/novel-c

    #Chemistry #CovalentInhibitors #ChemBio #DrugDiscovery

  54. Are you interested in novel covalent inhibitors and diverse strategies, through which you can find new chemistries for them?

    I am very excited that Madeline Kavanagh, Marc Baggelaar, Rita Petracca and I were awarded a Focus Session on "Covalent Inhibitors and where to find them" at the CHAINS conference by NWO to discuss exactly these topics. (1/3)

    nwochains.nl/programme/novel-c

    #Chemistry #CovalentInhibitors #ChemBio #DrugDiscovery